Carlini Celia Regina

Carlini earned her PhD from the Federal University of São Paulo, Brazil, in 1985. She was appointed professor at the Federal University of Rio de Janeiro and the Federal University of Rio Grande do Sul, and was a senior researcher at the Brain Institute of the Pontifical Catholic University of Rio Grande do Sul. After her retirement, in 2022, she worked as an invited professor at UFRGS and the Federal University of Health Sciences, Porto Alegre. She is a member of the Brazilian Academy of Sciences and a research productivity fellow of the Brazilian CNPq. Carlini was a pioneer in proving the non-enzymatic properties of ureases, including their insecticidal, antifungal, and pro-inflammatory, and neurotoxic effects in rodents. Now, she studies how the ureases produced by Helicobacter pylori and Proteus mirabilis might contribute to the onset of Alzheimer’s and Parkinson’s diseases. She was a referee for more than 60 international journals, science and technology funding agencies, and a member of the editorial board of Toxicon for 20 years, section editor of the Brazilian Journal of Medical and Biological Research. Since 2020, she is an executive editor of Current Neuropharmacology.